Editorial Board: Arch. Pharm. Chem. Life Sci. (10/2018).
- Published in:
- Archiv der Pharmazie, 2018, v. 351, n. 10, p. 1, doi. 10.1002/ardp.201870018
- Publication type:
- Article
Works matching IS 03656233 AND DT 2018 AND VI 351 AND IP 10
Results: 8
1
2
Some pyrazoles derivatives: Potent carbonic anhydrase, α‐glycosidase, and cholinesterase enzymes inhibitors.
- Published in:
- Archiv der Pharmazie, 2018, v. 351, n. 10, p. 1, doi. 10.1002/ardp.201800200
- By:
- Publication type:
- Article
3
Cover Picture: Arch. Pharm. Chem. Life Sci. (10/2018).
- Published in:
- Archiv der Pharmazie, 2018, v. 351, n. 10, p. 1, doi. 10.1002/ardp.201870017
- Publication type:
- Article
4
Xanthine oxidase inhibitory activity of new pyrrole carboxamide derivatives: In vitro and in silico studies.
- Published in:
- Archiv der Pharmazie, 2018, v. 351, n. 10, p. 1, doi. 10.1002/ardp.201800165
- By:
- Publication type:
- Article
5
Novel cinnamic acid–tryptamine hybrids as potent butyrylcholinesterase inhibitors: Synthesis, biological evaluation, and docking study.
- Published in:
- Archiv der Pharmazie, 2018, v. 351, n. 10, p. 1, doi. 10.1002/ardp.201800115
- By:
- Publication type:
- Article
6
Prospecting for cytotoxic and antiprotozoal 4‐aryl‐4H‐chromenes and 10‐aryldihydropyrano[2,3‐f]chromenes.
- Published in:
- Archiv der Pharmazie, 2018, v. 351, n. 10, p. 1, doi. 10.1002/ardp.201800100
- By:
- Publication type:
- Article
7
3‐(7‐Azaindolyl)‐4‐indolylmaleimides as a novel class of mutant isocitrate dehydrogenase‐1 inhibitors: Design, synthesis, and biological evaluation.
- Published in:
- Archiv der Pharmazie, 2018, v. 351, n. 10, p. 1, doi. 10.1002/ardp.201800039
- By:
- Publication type:
- Article
8
Overcoming resistance in non‐small‐cell lung cancer: A practical lesson for the medicinal chemist.
- Published in:
- Archiv der Pharmazie, 2018, v. 351, n. 10, p. 1, doi. 10.1002/ardp.201800037
- By:
- Publication type:
- Article